Keyphrases
Meta-analysis
100%
Systemic Review
100%
Review Analysis
100%
Metastatic Breast Cancer
100%
Locoregional Therapy
100%
Confidence Interval
88%
Hazard Ratio
88%
Overall Survival
66%
Non-associated
33%
Randomized Controlled Trial
22%
Intention-to-treat
22%
Tumor Subtype
22%
Locoregional
22%
In(III)
11%
Methodological Challenges
11%
Inconsistent Results
11%
Breast Cancer
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Systemic Therapy
11%
Standard of Care
11%
Metastatic Disease
11%
Primary Breast Tumor
11%
Triple Negative
11%
Visceral Disease
11%
Metastasis Sites
11%
Adjuvant Radiation
11%
Hormone Receptor-positive
11%
Overall Time
11%
Inverse Variance
11%
Cancer Subgroups
11%
Bone-only Disease
11%
Nursing and Health Professions
Confidence Interval
100%
Hazard Ratio
100%
Meta Analysis
100%
Metastatic Breast Cancer
100%
Overall Survival
75%
Disease
37%
Intention to Treat Analysis
25%
Neoplasm
25%
Health Care Quality
12%
Breast Cancer
12%
Metastasis
12%
Breast Tumor
12%
Systemic Therapy
12%
Gamma Urogastrone
12%
Critical Appraisal
12%
Epidermal Growth Factor Receptor 2
12%
Hormone Receptor
12%
Medicine and Dentistry
Hazard Ratio
100%
Meta-Analysis
100%
Metastatic Breast Cancer
100%
Overall Survival
75%
Disease
37%
Intention-to-Treat Analysis
25%
Randomized Controlled Trial
25%
Neoplasm
25%
Metastatic Carcinoma
25%
Breast Cancer
12%
Critical Appraisal
12%
Breast Tumor
12%
Systemic Therapy
12%
Epidermal Growth Factor Receptor 2
12%
Hormone Receptor
12%
Gamma Urogastrone
12%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Metastatic Breast Cancer
100%
Disease
50%
Randomized Controlled Trial
33%
Neoplasm
33%
Breast Cancer
16%
Metastasis
16%
Breast Tumor
16%
Epidermal Growth Factor Receptor 2
16%
Gamma Urogastrone
16%
Hormone Receptor
16%
Agricultural and Biological Sciences
Meta-Analysis
100%
Confidence Interval
100%
Epidermal Growth Factor Receptor
12%
Hormone Receptor
12%
Veterinary Science and Veterinary Medicine
Epidermal Growth Factor
100%